Movement Alert｜Hims & Hers Health Rises 5.45% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Improvement Signals Fuel Rally

Market Focus06-16

On June 16, Hims & Hers Health rose 5.45% in regular trading, reaching $31.83/share with turnover of approximately $290 million, reflecting sustained bullish momentum driven by multiple catalysts.

On the news front, Goldman Sachs recently raised its overall market expectations for GLP-1 weight-loss drugs, providing a tailwind for the company's expanding presence in the category. Additionally, tracked sales data showed that three of the last four weeks recorded year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals. The combination of an upgraded market outlook and improving operational metrics has reinforced bullish sentiment.

Earlier this month, the company completed its acquisition of Australian telehealth firm Eucalyptus, expanding its footprint into Australia, Canada, and Germany, which further solidifies its position as a leading global consumer health platform. Hims & Hers Health operates a multi-specialty telehealth platform connecting consumers with licensed healthcare professionals across mental health, sexual health, dermatology, and primary care.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1179483505?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 23:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179483505","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Hims & Hers Health Rises 5.45% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Improvement Signals Fuel Rally","media":"Market Focus","content":"<p><p>On June 16, Hims & Hers Health rose 5.45% in regular trading, reaching $31.83/share with turnover of approximately $290 million, reflecting sustained bullish momentum driven by multiple catalysts.</p><p>On the news front, Goldman Sachs recently raised its overall market expectations for GLP-1 weight-loss drugs, providing a tailwind for the company's expanding presence in the category. Additionally, tracked sales data showed that three of the last four weeks recorded year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals. The combination of an upgraded market outlook and improving operational metrics has reinforced bullish sentiment.</p><p>Earlier this month, the company completed its acquisition of Australian telehealth firm Eucalyptus, expanding its footprint into Australia, Canada, and Germany, which further solidifies its position as a leading global consumer health platform. Hims & Hers Health operates a multi-specialty telehealth platform connecting consumers with licensed healthcare professionals across mental health, sexual health, dermatology, and primary care.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hims & Hers Health Rises 5.45% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Improvement Signals Fuel Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hims & Hers Health Rises 5.45% in Regular Trading, Goldman Sachs GLP-1 Market Upgrade and Sales Improvement Signals Fuel Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-16 23:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 16, Hims & Hers Health rose 5.45% in regular trading, reaching $31.83/share with turnover of approximately $290 million, reflecting sustained bullish momentum driven by multiple catalysts.</p><p>On the news front, Goldman Sachs recently raised its overall market expectations for GLP-1 weight-loss drugs, providing a tailwind for the company's expanding presence in the category. Additionally, tracked sales data showed that three of the last four weeks recorded year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals. The combination of an upgraded market outlook and improving operational metrics has reinforced bullish sentiment.</p><p>Earlier this month, the company completed its acquisition of Australian telehealth firm Eucalyptus, expanding its footprint into Australia, Canada, and Germany, which further solidifies its position as a leading global consumer health platform. Hims & Hers Health operates a multi-specialty telehealth platform connecting consumers with licensed healthcare professionals across mental health, sexual health, dermatology, and primary care.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1179483505","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179483505","pubTimestamp":1781623078,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 16, Hims & Hers Health rose 5.45% in regular trading, reaching $31.83/share with turnover of approximately $290 million, reflecting sustained bullish momentum driven by multiple catalysts.On...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"运动警报|Hims&Hers Health常规交易上涨5.45%，高盛GLP-1市场升级和销售改善信号推动反弹","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"On June 16, Hims & Hers Health rose 5.45% in regular trading, reaching $31.83/share with turnover of approximately $290 million, reflecting sustained bullish momentum driven by multiple catalysts.On the news front, Goldman Sachs recently raised its overall market expectations for GLP-1 weight-loss drugs, providing a tailwind for the company's expanding presence in the category. Additionally, tracked sales data showed that three of the last four weeks recorded year-over-year positive sales growth, sending a clear signal of marginal improvement in business fundamentals. The combination of an upgraded market outlook and improving operational metrics has reinforced bullish sentiment.Earlier this month, the company completed its acquisition of Australian telehealth firm Eucalyptus, expanding its footprint into Australia, Canada, and Germany, which further solidifies its position as a leading global consumer health platform. Hims & Hers Health operates a multi-specialty telehealth platform connecting consumers with licensed healthcare professionals across mental health, sexual health, dermatology, and primary care.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1179483505","isCrawlerRequest":true}